Drug Trial Radar · NCT00673309
Assessment of Mechanisms of Improved Wound Healing
Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
644
Actual
Start
Jul 2000
Primary completion
Apr 2011
Study completion Apr 2013
Sponsor
- Lead sponsor
- The University of Texas Medical Branch, GalvestonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of General Medical Sciences (NIGMS)
- First posted
- May 7, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.
Conditions
- Burns
Interventions
Stable Isotope Infusion studyProcedure
Stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues. Includes collection of blood and tissues (muscle)
Insulin High DoseDrug
Insulin IV administered continuously throughout hospitalization until wounds are 95% healed.
oxandroloneDrug
Oxandrolone given daily throughout hospitalization until 95% wound healing.
PropranololDrug
Propranolol to be given daily throughout hospitalization until 95% wound healing.
Growth HormoneDrug
Recombinant Human Growth hormone to be administered daily until 95% wound healing.
Insulin Low DoseDrug
Insulin administered IV until 95% wound healing
IGF-1/IGFBP-3Drug
Insulin Like Growth Factor-1/Insulin like Growth Factor Binding Protein 3 administered until 95% wound healing
ItraconazoleDrug
Itraconazole administered until 95% wound healing
Growth Hormone and PropranololDrug
Growth Hormone and Propranolol given until 95% wound healing
Oxandrolone and PropranololDrug
Oxandrolone and Propranolol
Placebo or ControlDrug
Administration of Placebo or Control until 95% wound healing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Decrease Hypermetabolism as Measured by Stable Isotope Infusion StudyTime frame: Admission to burn unit to 95% wound healing
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Texas Medical Branch
Galveston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.